HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, March 16, 2007 (HealthDay News) -- Taking a daily medication to prevent migraine headaches can boost worker productivity and save companies money, a U.S. study shows.
Half of the 325 migraine-plagued workers in the study took the drug topiramate (brand name Topamax) each day, and the other half took a placebo.
The study was funded by Ortho-McNeil Neurologics Inc., the maker of Topamax.
The drug's effect on work absenteeism was minimal, say researchers from Thomas Jefferson University in Philadelphia. Among those taking the drug, average missed work time per week was one hour, compared to 1.5 hours for those taking the placebo.
However, the drug had a much greater effect on "presenteeism" -- days that employees were on the job but not able to work at full capacity due to a migraine. When the researchers added absenteeism and presenteeism together, they found that the total lost productive time for workers with migraines was 14.6 hours per month before they started taking topiramate, compared to 5.1 hours per month while they were taking the drug.
Workers taking the placebo also showed a decrease in total lost productive time when their presenteeism and absenteeism were added together, but the gain in productivity was higher among workers taking topiramate, the study said.
The findings are published in the March issue of the Journal of Occupational and Environmental Medicine.
It's estimated that migraines cost U.S. businesses up to $28.7 billion a year in lost productivity, according to background information in a news release about the study.
The American Academy of Family Physicians has more about migraine headaches.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on June 12, 2022